Abstract: A method of preparing a compound of formula (I), and pharmaceutically acceptable salts and solvates thereof.

Abstract: A work light having one or more light emitting diodes (LEDs) to provide a high intensity beam pattern. In one arrangement two LEDs are tilted away from each and in another arrangement one LED is used together with a shaped reflector to provide an elliptical beam.

Abstract: A particulate luminescent composition is disclosed that, when excited by electromagnetic radiation at a first frequency, emits electromagnetic radiation at a second frequency equal to or within 1500 cm?1 of the first frequency. The luminescent composition comprises substantially spherical particles having a weight average particle size of less than about 10 ?m and a particle size distribution such that at least about 90 weight percent of the particles are not larger than twice the average particle size.

Abstract: Polymers containing an acetal or ketal linkage and their use in lithographic photoresist compositions, particularly in chemical amplification photoresists, are provided. The polymer is prepared from at least one first olefinic monomer containing an acetal or ketal linkage, the acid-catalyzed cleavage of which renders the polymer soluble in aqueous base; and at least one second olefinic monomer selected from (i) an olefinic monomer containing a pendant fluorinated hydroxyalkyl group RH, (ii) an olefinic monomer containing a pendant fluorinated alkylsulfonamide group RS, and (iii) combinations thereof. The acetal or ketal linkage may be contained within an acid-cleavable substituent RCL in the first olefinic monomer. A method for using the photoresist compositions containing these polymers in preparing a patterned substrate is also provided in which the polymer is rendered soluble in aqueous base at a temperature of less than about 100° C.

Abstract: Provided are a method, system, and article of manufacture, wherein a plurality of processing nodes in a storage system are partitioned into a plurality of logical processing units, and wherein the plurality of logical processing units can respond to I/O requests from a host coupled to the storage system. At least two logical processing units are grouped, wherein data in a first storage coupled to a first logical processing unit of the least two logical processing units is mirrored by data in a second storage coupled to the second logical processing unit of the at least two logical processing units. In response to a failure of the first logical processing unit, an I/O request from the host is responded to via the second logical processing unit.

Abstract: A method for removing defects at high pressure and high temperature (HP/HT) or for relieving strain in a non-diamond crystal commences by providing a crystal, which contains defects, and a pressure medium. The crystal and the pressure medium are disposed in a high pressure cell and placed in a high pressure apparatus, for processing under reaction conditions of sufficiently high pressure and high temperature for a time adequate for one or more of removing defects or relieving strain in the single crystal.

Abstract: A chemical compound of formula (I) wherein R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4 and R5 are selected from hydrogen and alkyl; R6 and R7 are independently selected from hydrogen, halogen, hydroxyl, alkyl, aryl, amino, alkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, alkylsulfoxyl, nitro, carbonitrile, carbo-alkoxy, carbo-aryloxy and carboxyl; and A is a 5- or 6-membered ring optionally containing one or more heteroatoms wherein the atoms of the ring A, other than the unsaturated carbon atoms of the phenyl ring to which the ring A is fused, are saturated or unsaturated, and pharmaceutically acceptable salts, addition compounds and prodrugs thereof; and the use thereof in therapy, particularly as an agonist or antagonist of 5HT receptor, particularly a 5HT2C receptor, for instance in the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea,

Abstract: A chemical compound of formula (I) wherein R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4 and R5 are selected from hydrogen and alkyl; R6 and R7 are independently selected from hydrogen, halogen, hydroxyl, alkyl, aryl, amino, alkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, alkylsulfoxyl, nitro, carbonitrile, carbo-alkoxy, carbo-aryloxy and carboxyl; and A is a 5- or 6-membered ring optionally containing one or more heteroatoms wherein the atoms of the ring A, other than the unsaturated carbon atoms of the phenyl ring to which the ring A is fused, are saturated or unsaturated, and pharmaceutically acceptable salts, addition compounds and prodrugs thereof; and the use thereof in therapy, particularly as an agonist or antagonist of a 5HT receptor, particularly a 5HT2C receptor, for instance in the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea

Abstract: A chemical compound of formula (I) wherein R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4 and R5 are selected from hydrogen and alkyl; R6 and R7 are independently selected from hydrogen, halogen, hydroxyl, alkyl, aryl, amino, alkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, alkylsulfoxyl, nitro, carbonitrile, carbo-alkoxy, carbo-aryloxy and carboxyl; and A is a 5- or 6-membered ring optionally containing one or more heteroatoms wherein the atoms of the ring A, other than the unsaturated carbon atoms of the phenyl ring to which the ring A is fused, are saturated or unsaturated, and pharmaceutically acceptable salts, addition compounds and prodrugs thereof; and the use thereof in therapy, particularly as an agonist or antagonist of a 5HT receptor, particularly a 5HT2C receptor, for instance in the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea

Abstract: A receiver medium for inkjet printing includes a porous substrate, having on at least one surface thereof a porous ink-absorbent coating having a colloidal particulate material, a water-insoluble liner binder polymer, and optionally a film forming polymer dispersion. On printing, the medium rapidly absorbs ink to give a touch-dry surface. The receiver medium can also have a satin finish surface. Also disclosed is a method of making the receiver medium.

Abstract: A method comprises storing data relating to the wear of a component of at least one turbine system in a database of a system for processing wear related information, generating a displayable menu containing a plurality of user-selectable links respectively associated with software modules of the system, and receiving an on-line selection of one of the user-selectable links to enable the associated software module of the system to generate displayable content including information relating to the wear of the component of the turbine system. The selected module may enable a quantitative amount of the wear of the component or qualitative wear range characterizing the amount of the wear of the component to be input and received on-line. Alternatively, the selected module may enable a component type to be input and received on-line and display a component fleet leader.

Abstract: The present invention provides an improved process for the preparation of a polymorph of eletriptan hemisulphate.

Abstract: A foot support and abduction assembly includes an abductor configured for pivotal attachment proximate a foot end of a maternity bed. The foot support is configured for locating in a stowed position below the abductor, and a calf support is attached to an undersurface of the foot support. An upright assembly has a first end that is secured to the abductor for longitudinal movement along a length of the abductor, a second end to which the foot support is movably mounted, and a locking mechanism for selectively securing the upright assembly in one of a plurality of positions along the length of the abductor. The upright assembly is further configured for movement from a deployed position to a stowed position, and the locking mechanism is unlocked when the upright assembly is in the stowed position.

Abstract: Processor(s) operating a random access memory is subject to reboot processing which comprises clearing the random access memory. Registration is provided of a portion of the random access memory, the registration indicating that data stored in the registered portion of the random access memory is to be preserved during the reboot processing. In reboot processing, the processor responds to the registration, preventing data stored in the registered portion from clearing during the reboot processing.

Abstract: The present invention relates to a specific method accomplishing fast and specific identification of contaminating micro-organisms in large amounts of food stuffs. A method has been developed based on random genome fragments or Zipcode oligonucleotides and DNA microarray technology that overcomes the disadvantages of whole-genome DNA-DNA hybridisation. In particular, the present invention provides a method for characterising micro-organisms possibly present in a sample, comprising the steps of collecting said micro-organisms if present, extracting nucleic acids from said micro-organisms, specifically amplifying said nucleic acids, thereby providing an amplified nucleic acid mixture comprising the target nucleic acid in amplified form, and analysing the amplified nucleic acid mixture, whereby the said micro-organisms if present are characterised. The present invention further relates to the use of filters, microarrays and amplification steps in said method as well as a kit comprising the same.

Abstract: The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts, solvates and esters thereof. These compounds can be used to prepare pharmaceutical compositions for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.

Abstract: In a system for remotely controlling the supply of electric power to customer premises, each customer premises is fitted with a power-switching arrangement coupled to a paging receiver (5-1, 5-2, 5-3). A utility company supplying the electric power can input requests to a server (1), optionally via a terminal (2) or a network link (3). A software application running on the server generates a control instruction in response to a request and sends it to a paging service (4) for transmission over a paging network. When a paging message is received at one of said customer-premises paging receivers, if the control instruction is appropriately addressed the power-switching arrangement will put it into effect, for example to connect or reconnect the customer premises power supply.